Recursion Pharmaceuticals Inc.

NASDAQ: RXRX
Share price (3/26/25): $6.17
Market cap (3/26/25): $2.480 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Automatic shelf registration

Prospectus with selling stockholder info

Registration of securities for employees

Prospectus supplement for primary offering

Ownership Filter

Bumpus Namandje

Bumpus Namandje

News Filter

Bolsters Board of Directors With Former FDA Principal Deputy Commissioner Dr. Namandjé Bumpus and Mammoth Biosciences COO and CFO Elaine Sun

Provides Business Updates and Reports Fourth Quarter and Fiscal Year 2024 Financial Results

Investor Presentation

Other Events, Financial Statements or Exhibits

Change in Directors, Officers or Compensation

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Additional info about upcoming vote

Preliminary proxy related to merger

Other Filter

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Scanned paper annual report submission

Scanned paper annual report submission